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Physicians have long searched for an effective therapeutic agent against the
unusually resistant diseases, granuloma inguinale and lymphogranuloma yen-
ereum. Chancroid responds readily to antiseptic measures and the sulfonamide
compounds. Syphilis is controlled by penicillin or arsenicals and bismuth com-
pounds. Gonorrhea responds to the sulfonamides, penicillin or streptomycin. The
discovery that streptomycin was effective in the treatment of granuloma in-
guinale at last offered new hope to the patient with advanced and resistant
lesions. None of the antibiotics however, proved of any value in lymphogranu-
loma venereum until aureomycin and chloromycetin became available. This re-
port deals only with our experience in the management with aureomycin of 20
patients having granuloma inguinale and 20 with lymphogranuloma venereum.
GRANULOMA INGUINALE
Granuloma inguinale has been one of the recalcitrant diseases of the South. When treated
early and when the lesions were relatively small they responded to prolonged therapy with
the antimony compounds. However, relapses were common (1). Soon after streptomycin
became available Greenhlatt, Kupperman and Dienet (2) found it offered great hope for
the cure of granuloma inguinale. The average effective dose was found to be 20 grams of
streptomycin in 5 days. When this dosage schedule was employed in 95 cases of 142 patients
treated a cure rate of 90.4% was obtained. However, 5 streptomycin-resistant cases were
encountered. These patients received from 40 to 158 grams without benefit. All of these
resistant cases, as shown in Table I, subsequently have been effectively treated with oral
aureomycin and have remained healed (3). Four patients have now been followed for six
months and one for two and one-half months.
Aureomycin was used in 15 other patients and has proved most effective.
Four patients were treated by the intramuscular route. They received total doses
of from 420 to 1500 mgs. in from 7 to 23 days. In no instance was healing ac-
complished nor did Donovan bodies disappear from the deep tissues. Subse-
quefitly, all of these patients responded well to the oral administration of the
drug. These results are not in accord with the findings of Wright et al., who re-
ported two cures in granuloma inguinale treated intramuscularly with 2,020 and
560 mgs. respectively (4).
A total of 20 patients with granuloma inguinale were treated with oral aureo-
mycin and the results are shown in Tables I and II. The diagnosis was con-
firmed in all patients by smear and/or biopsy. An intradermal test with Donovan
body antigen was done in 10 patients and was positive in all instances. The first
3 patients were tried on a total dose of 5 grams given as 250 mgs. four times
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daily. There was early superficial healing of the lesions but Donovan bodies
were demonstrated in all cases by deep biopsy at the conclusion of treatment.
Subsequent therapy consisted of 25.5 to 37 more grams. This produced com-
plete healing of the lesions. These three patients had originally been strepto-
mycin-resistant (Table I).
One patient (Table II, Case 6) who received a total dose of less than 20 grams
of aureomycin had permanent healing of his lesions. This patient was a Negro
of 25 who had a 10 month old penile lesion approximately 10 sq. cm. in diameter
which had resisted 8 months of fuadin therapy. Four hundred twenty mgs. of
TABLE I
Aureomyein therapy in streptoeaycin-resistant grannloma inquinale
CASE AUREO5IYCIN SM.
TOTAL
DO5AOE AUREOMYCIN ORAL
TOTAL
DO5AOE RESULTS
FOLLOW-UP
0 *105.
Rig. g.
1 a) 20 mg. /d/7d
b) 20 mg. tid/8d
c) 20 mg. q4h/0d
140
400
800
d) 250 rog. qid/Sd
e) 250 log. 4—6/d/27d
5.0
37.0
No healing
No healing
No healing
Healing Incomplete
Healed after 18 d Healed
2 a) 20 mg tid/7d 420
b) 250 mg. qid/5d
e) 250 mg. 4—6/d/20d
5.0
25.5
No healing
Healed-Relapse
Healed after 11 d Healed
3* a) 250 mg. qid/5d
b) 250 log. qid/30d
5.0
30.0
Healed-Relapse
Healed Healed
4* a) 20 mg. q4h/8—l/6d 1020
b) 250 mg. qid/l4d
c) 100 log. qid/8d 25,)
No healing
Healing
Healed Healed
st a) 1 g. qid/5d 20% healed
b) 500 log. qid/lOd 7 0 80% healed )2k mos. follow-
c) 500 log. qid/5d 0. 80% healed up)
d) 500 n*g. qid/lOd J Healed
* Biopsies, however, revealed presence of Donovan bodies deep in tissue until 15th day in each case.
Donovan bodies did not disappear until 32 grabs of the drug were given.
aureomycin intramuscularly in 7 days likewise proved of no benefit, but subse-
quently1 therapy with a total of 10.8 grams of the drug orally in 20.5 days
produced complete healing in 6 days. He has remained well for 6 months.
Nine additional patients were treated on an arbitrary total dose of 20 grams.
Three of these received the drug as 1 gram every 6 hours for 5 days. All lesions
were completely healed within 21 days. T\vo have remained healed for 5 months
and 1 month respectively. However, the third patient relapsed at 3 months. She
showed only a small erosion about the clitoris of approximately 1 sq. cm. Dono-
van bodies u-crc demonstrated in smear from the deep tissues. This patient later
admitted to vomiting some of her drug. The relapsing lesion was entirely healed
at the completion of additional treatment with 20 grams of aureomycin in 10
days and has remained u-elI for two months.
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Five of these 9 patients received 20 grams of aureomycin spread over a 10
day period as 500 mgs. every 6 hours. Two patients were healed within 4 days
while one was not completely healed until 28 days following completion of
therapy. These patients have been followed from 1 to 3 months.
The ninth patient received 20 grams of aureomycin in 20 days. The dose was
reduced to 250 mgs. every 6 hours after the first 24 hours due to vomiting. She
tolerated the smaller dose; however, slight nausea continued throughout the
course of treatment.
Six of the earlier group of patients received larger doses of oral aureomycin
extending over a longer period of time. This was (lone to insure complete healing
8
9
10
11
12
13
14
15
16
17
18
19
20
1 gm. qid/5d
500 mg. qid/lOd
500 mg. qid/lOd
500 mg. qid/lOd
500 mg. qid/lOd
500 mg. qid/lOd
250 mg. qid/20d
500 mg. qid/15d
500 mg. qid/20d
500 mg. qid/30d
No healing
Healing incomplete
healed after 6 days
Healed after 12 days
Healed in 21 days
healed in 15 days
Healed in 9 days
healed in 21 days
Healed in 28 days
healed in 4 days
healed in 4 days
Healed in 6 days
1-lealed in 10 days
Healing (9 days)
Healed in 7 days
Healed
Healed
Healed (6 mos.)
Healed (6 mos.)
healed (6 mos.)
Healed (5 mos.)
Relapse at 3 mos. Healed
at completion of 20
gm./lOd (2 mos.)
Healed (1 mo.)
Healed (24 mos.)
Healed (3 mos.)
Healed (2 mos.)
Healed (1 mo.)
Healed (2 wks.)
when the dose was still experimental. Three of these 6, as stated above, had
shown healing but relapsed after receiving only 5 grams of the drug. When they
received from 26.5 to 42 grams over a 22 to 35 days period, all healed within 21
days and 2 were healed by the time therapy was completed. This group of pa-
tients has remained well for 6 months.
The remaining four patients (Cases 5, 18, 19 and 20) were deliberately treated
with more than 20 grams of aurcomycin because of the extensiveness of their
lesions. One woman received 30 grams in 15 days because the lesions covered
almost the entire vulva. The second patient was given 40 grams for large granulo-
matous lesions involving most of the penis and scrotom and extending into the
right inguinal region. These lesions had been present for 3 years. The third pa-
tient in this group was a Kegress who had lesions which had been present for
CASE AUREOMYCIN
TABLE II
Oral aoreomycin in granuloma inguinale
6
DOSAGE RESTILTA 8OLLOw-UP
(20 mg. tid/7d IM)
a) 100 mg. qid/7d
b) 100mg. q4li/134d
250 mg. qid/32d
250 mg. 4—6/d/32d
1 gm. qid/5d
1 gm. qid/5d
gm.
2.8
8.0
32
40
20
20
20
20
20
20
20
20
20
30
40
60
healed
Healed
Healed
(1 mo.)
(5 svks.)
(1 svk.)
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14 years and involved approximately 80 sq. cm. of the vulva. Donovan bodies
were demonstrated on deep smears after 20 grams of aureomycin administered
in 10 days. Following treatment with an additional 20 grams, the lesions were
80% healed and Donovan bodies could not be demonstrated. To insure healing,
a total dose of 60 grams in 30 days was given. The last patient (Case 5) presented
lesions covering 300 sq. cm. of the perigenital region. The disease had been
present for 4 years and had not responded to 2 years of fuadin therapy, induced
fever, roentgen ray therapy and 158 grams of streptomycin. Donovan bodies
were still present in the lesions until 32 grams of aureomycin had been given.
He was entirely healed upon completion of 70 grams in 30 days, and has re-
mained well for 2.5 months.
Duration of therapy
Healing of lesions of granuloma inguinale in these 20 patients occurred on an
average of 10 days after the completion of therapy. Four patients who had
received more than 30 grams were healed by the time their treatment was
finished. In only one patient was a period as long as 28 days required to ac-
complish healing. In this patient treatment was commenced the day after
delivery when she had sustained a complete tear through the granulomatous
tissue of the perineum.
Donovan bodies persisted in the lesions in all patients receiving parenteral
aureomycin therapy. In those patients who received at least 2 grams of oral
aureomycin daily an average of 3 days was required for the elimination of
Donovan bodies from the deep tissues. When only 1 gram per day in divided
doses was given an average of 11 days elapsed before Donovan bodies disap-
peared. On this regimen, 15 days was the longest time required and 4 days the
shortest.
Side effects
Aureomycin is a toxic drug, difficult to administer on an outpatient basis
since nausea, vomiting, and diarrhea are fairly common. One patient complained
of marked dizziness. Eleven of our 20 patients experienced nausea and 3 com-
plained of diarrhea. Although vomiting occurred in only 5 patients, it poses a
serious problem. This factor makes it difficult to estimate the amount of drug
lost. Persistent vomiting in one patient of this series made it necessary to de-
crease the individual dose from 500 mgs. to 250 mgs. The only relapse observed
among the patients receiving 20 grams or more of aureomycin occurred in an
individual who vomited during a treatment regimen of 1 gram every four hours
for a total of 20 grams in 5 days. Seventy percent of the patients with granuloma
inguinale experienced some side effect from aureomycin treatment.
LYMPHOGRANULOMA VENEREIJM
There are serious deficiencies in the effectiveness of the previously used drugs for lympho-
granuloma venereum. The antimoriial preparations are of little value. The sulfonamide
compounds, on the other hand, are more effective in the treatment of the early manifesta-
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tions of lymphogranulorna venereum than of the late complications such as elephantiasic
ulcerative processes and multiple draining sinuses. The serious side effects with the sulfona-
mides have placed an obstacle in the way of their prolonged use.
Wright and his co-workers (5) were the first to observe good effects from the use of
aureomycin in this disease. Our experience, at the University of Georgia, with aureomycin
administered intramuscularly has been limited to 3 patients. While the results were en-
couraging in these three cases thus treated, we observed equally good results in two patients
with buboes due to lymphogranuloma venereum who received no therapy whatsoever.
We have used aureomycin in 20 patients who presented various manifestations
of lymphogranuloma venereum. Three received the drug parenterally, while in
17 it was given orally.
The diagnosis of lymphogranuloma venereum in all patients was confirmed
by the Frei intradermal test and the serum complement fixation test. A serum
albumin and globulin determination was done on 8 of these patients and the
albumin/globulin ratio was reversed in 6. A confirmatory biopsy was performed
in 6 cases. The Frei test gave negative results in only one patient with definite
clinical lymphogranuloma venereum. The complement fixation in this case was
positive in a dilution of 1:480. A biopsy taken from the rectal mucosa confirmed
the diagnosis of proctitis due to lymphogranuloma venereum. As will be dis-
cussed in more detail later, she responded dramatically to treatment with aureo-
mycin. Only one patient in our series had a negative complement fixation test
for lymphogranuloma venereum. This was a Negro male, age 23, whose large
draining buboes had been present for 4 weeks. He had strongly positive intrader-
mal reactions with both human pus and Squibb's lygranum antigen.
Of the three patients treated with intramuscular injections of aureomycin
alone, two had early manifestations, one having a hubo of 7 days duration
and the other a penile lesion and a bubo present for 6 months. The first pa-
tient received 400 mgms. of aureomycin intramuscularly in 5 days and the other
140 mgms. in 7 days. The titer of the complement fixation test in one of these
patients dropped from a positive in the dilution of 1:128 to 1:64 w'ithin 10 days.
The clinical response in both was good. The buboes subsided within 11 days.
The third patient who received parenteral aureomycin had a rectal stricture of
36 years duration. This was dilated manually each day during her hospitalization.
She has now been followed for eight months. The tubular stricture is still present
but the patient has no rectal difficulty.
Seventeen additional patients have been treated with oral aureomycin in
total doses ranging from 5.25 to 85 grams. The daily dose has varied from 1
to 4 grams in four equally divided doses.
Six patients, as shown in Table III, had buboes. In all but one case, the
lesion was present less than 6 months. This patient had a matted mass of en-
larged inguinal nodes on the right of 5 years duration. Two months prior to
admission a draining sinus had appeared. The drainage stopped after 1 week
of sulfathiazole, but the mass did not decrease in size. Upon completion of 20
grams of aureomycin in 10 days the mass was reduced to 50% its original size.
Three other patients in this group received a total of 20 grams of aureomycin in
from 5 to 14 days; one w'ith large draining bilateral buboes received 30 grams
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within 15 days; only one received as little as 5 grams in 10 days. The response in
this latter case was only fair, the buboes subsiding in 6 weeks. On the whole
the response was considered good in 3 patients, fair in 4 and poor in 1.
One patient had multiple draining sinuses in both inguinal regions and ex-
tending down between scrotum and thighs on either side. These had been present
for 2 years and had not responded to repeated courses of penicillin and sulf a-
thiazole. Upon completion of 40 grams of chloromycetin in 20 days he was
approximately 50% improved, however, the lesions relapsed within a week. He
was then retreated with 500 mgms. of aureomycin every 6 hours to a total
of 20 grams. Two weeks after completion of this therapy he was 90% improved.
Eleven women suffering from rectal strictures in addition to other late com-
plications of lymphogranuloma venereum were treated with aureomycin. These
TABLE III
LESION DURATION TRERAPY BEFORE-AFTER RESULTS
Bubo 2 wks. Untreated 1:240 1:240 Good. Subsided in 5 days.
Bubo 4 wks. Untreated 1:120 1:120 Good. Subsided in 7 days.
Penile lesion, 6 mos. 140 mg./7d TM. Good. Subsided in 11 days.
bubo
Bubo 1 wk. 400 mg/Sd I.M. 1:128 1:64 Good. Subsided rapidly.
Buboes 3 wks. 5 gm./lOd (oral) 1:60 1:120 Fair. Subsided in 6 wks.
Buboes 1 wk. 20 gm./14d (oral) 1:240 1:240 Fair. Subsided in 8 wks.
Buboes 4 wks. 30 gm./15d (oral) Neg. Neg. Fair. Buboes subsiding slowly.
Buboes 3 wks. 20 gm/Sd (oral) 1:060 1 :960 Poor. Buhoes larger in 3 wks.
Buboes 1 wk. 20 gm./lOd (oral) 1:480 1:4S0 Fair. Buboes skbsiding in 4
wks.
Bubo 5 yrs. 20 gm./lOd (oral) 1:480 Good. Subsiding in I wk.
Multiple drain- 2 yrs. 20 gm./13d (oral) 1:240 1:240! Good. Drainage 00% better in
ining sinuses 2 wks.
are illustrated in Table IV. Their symptoms had been present for from 2 to 36
years. The result in one treated with parenteral aureomycin, has already been
discussed. The remaining 10 were treated orally. Eight of these patients experi-
enced rectal discharge and/or bleeding from which they had suffered for from
2 to 10 years. An additional patient exhibited elephantiasis of the vulva in ad-
dition to a rectal stricture. Severe vomiting necessitated discontinuation of the
drug after approximately 7 grams had been given. The patient subsequently
died of uremia as a complication of chronic glomerulonephritis. Another pa-
tient was taken off aureomycin after 5.25 grams in 10 days because of persistent
vomiting. The tenth patient in this group had, in addition to a rectal stricture,
a small ulcer of the vulva diagnosed on biopsy as lymphogranuloma venereum.
The remaining 8 patients in this group who tolerated the oral administration
of the drug sufficiently well to complete their treatment received from 12 to 85
grams of aureomycin over a period of from 7 to 80 days. The best results were
obtained in 3 patients who received 12, 20, and 22.5 grams respectively. All had
rectal strictures and proetitis with discharge. The discharge had stopped by the
time treatment was completed and the strictures in two were improved following
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daily manual dilatation during the aureomycin treatment. The third patient
had a colostomy done 7 years ago. One has been followed 1 month, another 3,
and the other 6 months. One patient who received 27.25 grams of aureomycin
in 18 days had a rectal stricture and a small ulcer of the vulva which was di-
agnosed on biopsy as due to lymphogranuloma venereum. The stricture im-
proved with daily manual dilatation, but the ulcer failed to heal. Another
patient with a rectal stricture, proctitis and a perianal ulcer responded only alter
80 grams within 76 days. A young Negress of 28 who entered the hospital with
a distended abdomen, prolonged elevated temperature, marked weight loss,
elephantiasis of the vulva, and lymphorroids, rectal stricture and profuse bloody
Good. Stricture dilated. (Followed
8 mos.)
Good. Discharge stopped hy end of
rx. (Followed 6 mos.)
Fair. Stricture dilated. Ulcer no-
improved.
Fair. Proctitia better. Ulcer healed
in 6 wks.
Good. Stricture dilated. Discharge
stopped. (3 moe.)
Fair. Discharge improved by end of
treatment.
Good. Discharge stopped by end of
treatment.
Good. Diachaige stopped by end of
treatment. (2 wks.)
Good. Temp. normal in 24 lire. Die-
charge better.
Treatment discontinued, vomiting.
(Died—glomerulo.oephritie)
Treatment discontinued, vomiting.
rectal discharge responded well to aureomycin. The temperature became normal
and the distention began to decrease within 24 hours with 500 mgms. four
times daily. However, 85 grams of aureomycin was required to check the rectal
discharge. Another patient with a rectal stricture and discharge was about 60%
improved at the completion of 28 grams in 9 days. The final patient was a woman
with a rectal stricture and profuse bloody discharge of 10 years duration. Her
rectal discharge had entirely ceased upon completion of 50 grams of aureomycin
given as 1 gram per day. The results were good in 5 patients and fair in 3.
Side effects
Toxic reactions to the drug were more frequent and more severe in the group
having rectal strictures than in those with buhoes or draining sinuses. Seventy
percent of the patients experienced some side effects. Fourteen of the 20 patients
complained of nausea, while 4 had diarrhea and 7 vomiting. Vomiting \vas so
severe in 2 patients as to necessitate stopping the drug.
TABLE IV
Aureomycin in rectal strictures, etc. of tyotphoyranulorna venereum
TITERS BE-
FORE-ArTek RESULTSLESION PURATION
Rectal 5tricture 36 yre.
Rectal Stricture, Proetitis 2 yra.
Volvar Ulcer, Rectal 10 yre. (?)
5tricture
Rectal 5tricture, Perianal 6 moe. (?)
Ulcer, Proctitis
Rectal Stricture, Proctitis 10 yre. (?)
Rectal 5tricture, Proctitie 12 yre.
Rectal 5tricture, Proctitia 7 yrs.
Rectal 5tricture, Proctitia 10 yre.
TOERAFT
140 mg./7d SM
12 mg./12d (oral)
27 gm./18d (oral)
80 gm./76d (oral)
20 gm./7d (oral)
28 gm/Sd (oral)
22.5 gni./22.Sd (oral)
1:240
1:240
1:480
1:960
1:480
1:480
1:240
1:240
1:240
1:980
1:480
1:480
1:460
1:480
1:480
Rectal 5tricture, Proctitie,
Lymphorrhoide
Rectal 5tricture, Elephan-
tiasis
Rectal 5tricture, Proetitis
2 yre. (?)
8 yre.
10 yre.
50 gm/SOd (oral) 1:480
85 gm./47d (oral) 1:480
7 g,n./7d (oral) 1:240
5k gm./lOd (oral) 1:400
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CONCLUSIONS
A. Aureomycin is very effective in the treatment of granuloma inguinale
1. Twenty patients have now been treated. Four who received parenteral
aureomycin failed to respond. The lesions of 19 of the 20 patients
healed with one course of oral aureomycin. Only one relapse occurred.
This took place 3 months after therapy. The lesion responded to Fe-
treatment with the same drug.
2. The minimum effective dose of aureomycin in granuloma inguinale
appears to be 20 grams in a period of 10 days. However,-prolonged
therapy is necessary for the cure of the patient with extensive lesions.
B. Aureomycin in our hands proved of more value in the treatment of the
late manifestations of lymphogranuloma venereum than in the relatively
early case with buboes.
1. Of the 8 patients with buboes the results were good in 3, fair in4, and
poor in 1.
2. A relatively good result was obtained in 1 patient with multiple draining
sinuses of 2 years duration.
3. In 9 out of 11 patients with rectal strictures and/or proctitis the results
in those who tolerated the drug were good in 6 and fair in 3.
4. The drug had to be discontinued in 2 patients because of intensive
vomiting.
5. The response of proctitis due to lymphogranuloma venereum is good.
6. There was marked improvement in those with rectal strictures when
daily manual dilatations were done during the course of aureomycin
therapy. If this procedure is followed, colostomies can be almost entirely
avoided.
7. Ulcerative lesions of lymphogranuloma venereum respond poorly.
8. The minimum effective dose for buboes is between 20 to 30 grams of
aureomycin given as 500 mgs. four times daily, while for proctitis,
rectal strictures, etc., approximately 40 to 80 grams or more is re-
quired.
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